{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:22:20Z","timestamp":1787008940996,"version":"build-2736575974"},"reference-count":21,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Inflammatory bowel disease (IBD) treatment in the elderly is challenging in part because of increased risk of infections. The aim of our study was to determine the absolute and relative risk of infections among the elderly IBD patient population and to identify factors affecting the risk of infections in the overall IBD patient population.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A retrospective study of patients with IBD initiating corticosteroids, immunomodulators (IM), or biologic therapy (January 2010\u2013December 2014) was conducted using the Truven Market Scan database. IM and biologic exposure were assessed in a time-dependent manner. ICD-9 codes identified infection during follow-up. A Cox proportional hazards model was fitted to gauge the association between age, other covariates, and infection risk.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n We identified 63,759 patients with IBD. We found 2664 infections (incidence rate [IR] = 16.95\/100 person-years) among 8788 elderly patients with IBD and 10,515 (IR = 10.49\/100 person-years) among the nonelderly group. Pneumonia (39.8%), sepsis (13.2%), and candidiasis (12.9%) were the most common infections in the elderly. Factors associated with a higher risk of infection included being elderly (HR: 1.27, P < 0.0001), anti-TNF therapy (HR: 1.64, P < 0.0001), IM therapy (HR: 1.32, P < 0.0001), and polypharmacy (HR: 1.32, P < 0.0001).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Advanced age, anti-TNF (biologic) therapy, and IM therapy were associated with an increased risk of infection. Pneumonia was the most common infection among the elderly IBD population. Physicians should be mindful of these risks when prescribing medications for elderly patients with IBD, and ensure their patients are adequately vaccinated.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/ibd\/izz065","type":"journal-article","created":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T12:20:10Z","timestamp":1555158010000},"source":"Crossref","is-referenced-by-count":16,"title":["Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis"],"prefix":"10.1093","author":[{"given":"Nabeel","family":"Khan","sequence":"first","affiliation":[{"name":"University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vallarino","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals U.S.A., Inc., Deerfield, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Lissoos","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals U.S.A., Inc., Deerfield, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Darr","sequence":"additional","affiliation":[{"name":"Baylor University Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Luo","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals U.S.A., Inc., Deerfield, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,13]]},"reference":[{"key":"2019071109054563600_CIT0001","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet."},{"key":"2019071109054563600_CIT0002","article-title":"The rising burden of inflammatory bowel disease in North America from 2015 to 2025: a predictive model","volume":"110:p S829","author":"Coward","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2019071109054563600_CIT0003","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/j.gastro.2017.10.034","article-title":"Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden","volume":"154","author":"Everhov","year":"2018","journal-title":"Gastroenterology."},{"key":"2019071109054563600_CIT0004","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/apt.14494","article-title":"Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study","volume":"47","author":"Ma\u00f1osa","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"2019071109054563600_CIT0005","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/ecco-jcc\/jjw054","article-title":"Systematic review and meta-analysis: phenotype and clinical outcomes of older-onset inflammatory bowel disease","volume":"10","author":"Ananthakrishnan","year":"2016","journal-title":"J Crohns Colitis."},{"key":"2019071109054563600_CIT0006","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MIB.0000000000000993","article-title":"Risk of surgery and mortality in elderly-onset inflammatory bowel disease: a population-based cohort study","volume":"23","author":"Nguyen","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"2019071109054563600_CIT0007","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","author":"American Geriatrics Society 2015 Updated Beers Criteria Update Expert Panel","year":"2015","journal-title":"J Am Geriatr Soc."},{"key":"2019071109054563600_CIT0008","first-page":"8","article-title":"International variation in medication prescription rates among elderly patients with inflammatory bowel disease","volume":"11","author":"Benchimol","year":"2013","journal-title":"J Crohns Colitis."},{"key":"2019071109054563600_CIT0009","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s10620-012-2083-x","article-title":"Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity","volume":"57","author":"Juneja","year":"2012","journal-title":"Dig Dis Sci."},{"key":"2019071109054563600_CIT0010","first-page":"1392","article-title":"Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease","volume":"21","author":"Parian","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2019071109054563600_CIT0011","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cgh.2010.09.026","article-title":"Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease","volume":"9","author":"Cottone","year":"2011","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2019071109054563600_CIT0012","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ajg.2014.313","article-title":"Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases","volume":"109","author":"Brassard","year":"2014","journal-title":"Am J Gastroenterol."},{"key":"2019071109054563600_CIT0013","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","article-title":"Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases","volume":"7","author":"Ananthakrishnan","year":"2013","journal-title":"J Crohns Colitis."},{"key":"2019071109054563600_CIT0014","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1086\/313947","article-title":"Clinical relevance of age-related immune dysfunction","volume":"31","author":"Castle","year":"2000","journal-title":"Clin Infect Dis."},{"key":"2019071109054563600_CIT0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","article-title":"Ageing and infection","volume":"2","author":"Gavazzi","year":"2002","journal-title":"Lancet Infect Dis."},{"key":"2019071109054563600_CIT0016","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00535-012-0686-9","article-title":"A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"48","author":"Naganuma","year":"2013","journal-title":"J Gastroenterol."},{"key":"2019071109054563600_CIT0017","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"Toruner","year":"2008","journal-title":"Gastroenterology."},{"key":"2019071109054563600_CIT0018","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.21812","article-title":"Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis","volume":"65","author":"Widdifield","year":"2013","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"2019071109054563600_CIT0019","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MIB.0000000000000953","article-title":"Assessment of gaps in care and the development of a care pathway for anemia in patients with inflammatory bowel diseases","volume":"23","author":"Hou","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"2019071109054563600_CIT0020","first-page":"273","article-title":"Healthcare maintenance in elderly patients with inflammatory bowel disease","volume":"30","author":"Shrestha","year":"2017","journal-title":"Ann Gastroenterol."},{"key":"2019071109054563600_CIT0021","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG clinical guideline: preventive care in inflammatory bowel disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izz065\/28927475\/izz065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T09:05:57Z","timestamp":1562835957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article\/doi\/10.1093\/ibd\/izz065\/5455214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,13]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1093\/ibd\/izz065","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,13]]},"article-number":"izz065"}}